Morgan Stanley analyst Andrew McLeod upgraded Macquarie Technology Group to Overweight from Underweight with a price target of A$100, up from A$50. The financial and strategic value of the company's DC assets are undervalued, the analyst tells investors in a research note. While the structural tailwinds for DCs are well known, but AI is now set to drive the need for higher compute power over next 3-5 years, the firm added.
- Forums
- ASX - By Stock
- MAQ
- Macquarie Technology Group double upgraded to Overweight from Underweight at Morgan Stanley
MAQ
macquarie technology group limited
Add to My Watchlist
1.80%
!
$66.27

Macquarie Technology Group double upgraded to Overweight from Underweight at Morgan Stanley
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$66.27 |
Change
1.170(1.80%) |
Mkt cap ! $1.708B |
Open | High | Low | Value | Volume |
$65.30 | $66.67 | $65.23 | $3.039M | 45.88K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 120 | $66.09 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$66.48 | 136 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 120 | 66.090 |
1 | 120 | 66.010 |
1 | 45 | 66.000 |
2 | 198 | 65.990 |
1 | 120 | 65.940 |
Price($) | Vol. | No. |
---|---|---|
66.480 | 136 | 2 |
66.510 | 120 | 1 |
66.590 | 140 | 2 |
66.660 | 120 | 1 |
66.740 | 120 | 1 |
Last trade - 16.13pm 27/06/2025 (20 minute delay) ? |
Featured News
MAQ (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online